Ernexa Therapeutics Inc. (ERNA) stock

ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30

$1.79−0.14 (-7.25%)

Close on Nov 12, 2026Market cap $2.92MP/E –Yield –

Ernexa Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Ernexa Therapeutics's EV/EBITDA was 383.1× on Oct 31, 2019.

Period	Period end	Value	Change (pts)
2019	Oct 31, 2019	383.1×	−565.4
2011	Apr 29, 2011	948.5×	–

See a number that looks wrong?